Related references
Note: Only part of the references are listed.Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia
Alessandra Ferrajoli et al.
BLOOD (2013)
Mutant p53 drives invasion in breast tumors through up-regulation of miR-155
P. M. Neilsen et al.
ONCOGENE (2013)
MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia
Marek Mraz et al.
BLOOD (2012)
LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas
Yong Zhang et al.
BLOOD (2012)
The B-cell receptor signaling pathway as a therapeutic target in CLL
Jennifer A. Woyach et al.
BLOOD (2012)
miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes
Dan-Xia Zhu et al.
CARCINOGENESIS (2012)
The Role of B Cell Receptor Stimulation in CLL Pathogenesis
Laurens P. Kil et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
SOCS1 is significantly up-regulated in Nutlin-3-treated p53wild-type B chronic lymphocytic leukemia (B-CLL) samples and shows an inverse correlation with miR-155
Maria Grazia di Iasio et al.
INVESTIGATIONAL NEW DRUGS (2012)
Molecular pathogenesis of chronic lymphocytic leukemia
Gianluca Gaidano et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Downregulation of Inflammatory MicroRNAs by Ig-like Transcript 3 Is Essential for the Differentiation of Human CD8+ T Suppressor Cells
Chih-Chao Chang et al.
JOURNAL OF IMMUNOLOGY (2012)
The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
Yair Herishanu et al.
BLOOD (2011)
MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia
Karin Vargova et al.
BLOOD (2011)
Role of microRNA-155 in autoimmunity
Rui-Xue Leng et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Intraclonal Complexity in Chronic Lymphocytic Leukemia: Fractions Enriched in Recently Born/Divided and Older/Quiescent Cells
Carlo Calissano et al.
MOLECULAR MEDICINE (2011)
Quantitative Proteomics Identify Novel miR-155 Target Proteins
Christopher Loessner et al.
PLOS ONE (2011)
microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival
Simona Rossi et al.
BLOOD (2010)
MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application
S. Patrick Nana-Sinkam et al.
CANCER GENETICS AND CYTOGENETICS (2010)
Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group
Torsten Haferlach et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Karyotype-specific microRNA signature in chronic lymphocytic leukemia
Rosa Visone et al.
BLOOD (2009)
Onco-miR-155 targets SHIP1 to promote TNFα-dependent growth of B cell lymphomas
Irene M. Pedersen et al.
EMBO MOLECULAR MEDICINE (2009)
MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes
Marek Mraz et al.
LEUKEMIA & LYMPHOMA (2009)
Inositol phosphatase SHIP1 is a primary target of miR-155
Ryan M. O'Connell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage
Sergei B. Koralov et al.
CELL (2008)
miRNA analysis in B-cell chronic lymphocytic leukaemia:: proliferation centres characterized by low miR-150 and high BIC/milk-155 expression
M. Wang et al.
JOURNAL OF PATHOLOGY (2008)
ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia
Liguang Chen et al.
BLOOD (2008)
Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis
S. Marton et al.
LEUKEMIA (2008)
MicroRNA-155 regulates the generation of immunoglobulin class-switched plasma cells
Elena Vigorito et al.
IMMUNITY (2007)
Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells
Dimitar G. Efremov et al.
AUTOIMMUNITY REVIEWS (2007)
Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma
J. Kluiver et al.
ONCOGENE (2007)
BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-κB pathway
Tomoyuki Endo et al.
BLOOD (2007)
Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice
S Costinean et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia
GA Calin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas
J Kluiver et al.
JOURNAL OF PATHOLOGY (2005)
Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1α
M Nishio et al.
BLOOD (2005)
Accumulation of miR-155 and BIC RNA in human B cell lymphomas
PS Eis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia
LZ Rassenti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-κB activation pathways
B Zarnegar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia
LG Chen et al.
BLOOD (2002)
Identification of tissue-specific microRNAs from mouse
M Lagos-Quintana et al.
CURRENT BIOLOGY (2002)
Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2SH2 decoy proteins on FcγRIIB1-effector interactions and inhibitory functions
K Nakamura et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
